Clinical Trial Update: Oestradiol Pre-treatment in an Ultrashort Flare GnRH Agonist/GnRH Antagonist Protocol in Poor Responders Undergoing IVF [Phase 2, Phase 3]

View source ↗

Summary

This Phase 2/Phase 3 trial evaluates estradiol pre-treatment within an ultrashort flare GnRH agonist/antagonist protocol for poor responders undergoing in vitro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• Cetrorelix (Cetrorelix acetate)
• ESTRADIOL (Estradiol)
• Triptorelin (triptorelin)

Snippet

Sponsor: National and Kapodistrian University of Athens | Conditions: Infertility | Phase 2, Phase 3 | Status: TERMINATED